Category Archives: CLSA Wire

CLSA Report: Understanding Inflammatory Bowel Disease (IBD)

More than 3 million Americans suffer from Inflammatory Bowel Disease (IBD), an umbrella term for two distinct conditions – Crohn’s disease and ulcerative colitis. Download CLSA’s latest report to learn more about this disease, view patient stories, and learn how public policies can improve patient access to IBD therapies.

Federal Update: Tax Reform & Impact on the Life Sciences Sector

Congress is currently advancing legislation in both chambers to significantly overhaul the U.S. tax code. Historically, CLSA has focused our tax-related advocacy efforts around: (1) calling for an update and making permanent of the R&D Tax Credit, (2) protecting the Orphan Drug Tax Credit (ODTC), and (3) opposing the creation of and later calling for a repeal of the medical device tax.